0.9600
-0.0350
(-3.52%)
As of 12:04:05 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.38 | -0.4 | -1.62 | -1.68 |
| Low Estimate | -0.41 | -0.43 | -1.73 | -1.96 |
| High Estimate | -0.37 | -0.38 | -1.55 | -1.34 |
| Year Ago EPS | -0.3 | -0.02 | -1.14 | -1.62 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.37 | -0.36 | -0.36 | -0.38 |
| EPS Actual | -0.3 | -0.02 | -0.37 | -0.45 |
| Difference | 0.07 | 0.34 | -0.01 | -0.07 |
| Surprise % | 19.64% | 94.41% | -3.35% | -18.42% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.38 | -0.4 | -1.62 | -1.68 |
| 7 Days Ago | -0.39 | -0.41 | -1.64 | -1.73 |
| 30 Days Ago | -0.39 | -0.41 | -1.67 | -1.92 |
| 60 Days Ago | -0.39 | -0.41 | -1.67 | -1.92 |
| 90 Days Ago | -0.39 | -0.41 | -1.67 | -1.85 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PMVP | -27.78% | -1,900.00% | -41.81% | -4.12% |
| S&P 500 | 6.68% | 6.74% | 9.91% | 14.34% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/20/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/30/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/14/2024 |
| Initiated | Craig-Hallum: Buy | 5/13/2024 |
| Initiated | Jefferies: Buy | 4/12/2024 |
Related Tickers
HLVX HilleVax, Inc.
1.4400
-0.69%
KZR Kezar Life Sciences, Inc.
4.0500
-10.00%
THRD Third Harmonic Bio, Inc.
3.3800
-5.31%
EPIX ESSA Pharma Inc.
1.5150
-4.10%
SPRO Spero Therapeutics, Inc.
0.5968
-4.36%
RPTX Repare Therapeutics Inc.
1.0100
-3.81%
IKNA Ikena Oncology, Inc.
1.1500
-4.17%
SEER Seer, Inc.
1.6400
-1.20%
IPSC Century Therapeutics, Inc.
0.4301
-6.30%
ASMB Assembly Biosciences, Inc.
8.72
-6.34%